Search results for "Prostate cancer"
Be on alert for blood cancer precursors
Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
https://immattersacp.org/archives/2023/07/be-on-alert-for-blood-cancer-precursors.htm
1 Jul 2023
Make screening for prostate cancer an individual choice, USPSTF says
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
https://immattersacp.org/weekly/archives/2018/05/15/1.htm
15 May 2018
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Surgery performs better than radiotherapy for non-metastatic prostate cancer
Surgery was associated with better survival than radiotherapy in men with non-metastatic prostate cancer, according to a large observational study with follow-up as long as 15 years.
https://immattersacp.org/weekly/archives/2014/03/11/5.htm
11 Mar 2014
Sorting through the science of PSA screening
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
https://immattersacp.org/archives/2022/07/sorting-through-the-science-of-psa-screening.htm
1 Jul 2022
Guidelines suggest more informed consent for prostate cancer screening
MKSAP Quiz: optimal management of coronary artery disease
https://immattersacp.org/weekly/archives/2010/03/09/2.htm
9 Mar 2010
Prostate cancer treatment options result in similar 15-year outcomes
Functional outcomes among men undergoing prostatectomy or radiotherapy for prostate cancer differed at two and five years of follow-up, but significant differences were no longer present by 15 years, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/4.htm
5 Feb 2013
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023
Decision aids increased knowledge about prostate cancer but didn't affect screening rates
Decision aids improved participants' informed decision making about prostate cancer screening but did not change the actual screening rates, a study found.
https://immattersacp.org/weekly/archives/2013/08/06/2.htm
6 Aug 2013
Age, comorbidity should inform decisions on how to treat low- or intermediate- risk prostate cancer
Older men with prostate cancer and multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this when deciding between conservative management and aggressive treatment for low- or intermediate-risk disease, a study concluded.
https://immattersacp.org/weekly/archives/2013/05/21/2.htm
21 May 2013